T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELL
1151
DELISTED
PhenomeX Inc. Common Stock
CELL
| $35.3M | ﹤0.01% |
788,692
-278,997
| -26% | -$12.9M |
|
|
AEPPZ
1152
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $35.3M | ﹤0.01% |
691,126
+33,432
| +5% | +$1.69M |
|
1153
Dell
DELL
$320B
| $35.3M | ﹤0.01% |
698,178
+461,572
| +195% | +$23.1M |
|
1154
Qorvo
QRVO
$8.67B
| $35.2M | ﹤0.01% |
179,886
-2,154
| -1% | -$397K |
|
1155
Tapestry
TPR
$25.9B
| $35.1M | ﹤0.01% |
806,871
-58,616
| -7% | -$2.62M |
|
1156
Western Digital
WDC
$168B
| $35M | ﹤0.01% |
650,703
-3,427
| -0.5% | -$185K |
|
1157
Emergent Biosolutions
EBS
$230M
| $34.9M | ﹤0.01% |
554,036
-221,018
| -29% | -$14.2M |
|
1158
Caesars Entertainment
CZR
$6.04B
| $34.6M | ﹤0.01% |
333,857
-18,532
| -5% | -$1.87M |
|
1159
Extra Space Storage
EXR
$31B
| $34.6M | ﹤0.01% |
211,317
-1,688
| -0.8% | -$253K |
|
1160
Chemed
CHE
$7.02B
| $34.3M | ﹤0.01% |
72,362
-25,014
| -26% | -$12M |
|
1161
Invesco
IVZ
$14.3B
| $34.2M | ﹤0.01% |
1,280,754
-27,066
| -2% | -$738K |
|
|
CMLFU
1162
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $34.2M | ﹤0.01% |
2,090,987
-56,867
| -3% | -$823K |
|
1163
Xylem
XYL
$28.1B
| $34.1M | ﹤0.01% |
284,552
-9,528
| -3% | -$1.09M |
|
|
PPL
1164
PPL Corp
PPL
$26.8B
| $34.1M | ﹤0.01% |
1,220,305
-42,466
| -3% | -$1.23M |
|
1165
Ameresco
AMRC
$1.47B
| $34.1M | ﹤0.01% |
543,592
-43,798
| -7% | -$2.36M |
|
|
GRMN
1166
Garmin
GRMN
$59.8B
| $34M | ﹤0.01% |
235,106
-546
| -0.2% | -$76.7K |
|
1167
Ventas
VTR
$46.3B
| $33.9M | ﹤0.01% |
594,084
-3,386
| -0.6% | -$189K |
|
|
DAWN
1168
DELISTED
Day One Biopharmaceuticals
DAWN
| $33.4M | ﹤0.01% |
+1,505,396
| New | +$31.4M |
|
1169
Carnival Corporation Ltd
CCL
$38.9B
| $33.4M | ﹤0.01% |
1,268,137
+7,979
| +0.6% | +$223K |
|
1170
Dover
DOV
$28B
| $33.4M | ﹤0.01% |
221,516
-6,734
| -3% | -$994K |
|
1171
Vertiv
VRT
$111B
| $33.2M | ﹤0.01% |
1,215,437
-1,287,684
| -51% | -$30.8M |
|
|
PFHD
1172
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $33.2M | ﹤0.01% |
1,840,862
+120
| +0% | +$2.14K |
|
1173
BridgeBio Pharma
BBIO
$15.9B
| $33.1M | ﹤0.01% |
543,165
-62,825
| -10% | -$3.59M |
|
1174
Seres Therapeutics
MCRB
$47.4M
| $33.1M | ﹤0.01% |
69,392
-1,475
| -2% | -$622K |
|
1175
KeyCorp
KEY
$24.6B
| $32.9M | ﹤0.01% |
1,595,609
-42,380
| -3% | -$920K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.